Categorie -wet- en regelgeving

bv CGR, GDPR

wet- en regelgeving

Groen licht voor middelen bij huidinfectie en RA

7 november 2019

Arts en Apotheker

wet- en regelgeving

European Commission approves new indication for Dupixent in chronic rhinosinusitis with nasal polyposis

4 november 2019

Pharma Biz

wet- en regelgeving

EMA’s safety committee recommends restriction on use of Lemtrada for multiple sclerosis patients

4 november 2019

Pharma Biz

wet- en regelgeving

EMA validates Vertex’s MAA for elexacaftor, tezacaftor & ivacaftor triple combination treatment in CF

4 november 2019

Pharma Biz

wet- en regelgeving

EMA’s PRAC committee recommends Xeljanz to be used with caution for all patients at high risk of blood clots

4 november 2019

Pharma Biz

wet- en regelgeving

Astellas' Xospata gets European approval as monotherapy for patients with relapsed/refractory AML with FLT3 mutation

28 oktober 2019

Pharma Biz

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer